2012
DOI: 10.1038/scibx.2012.668
|View full text |Cite
|
Sign up to set email alerts
|

Liquid biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
(6 reference statements)
0
1
0
Order By: Relevance
“…These include circulating tumor DNA (ctDNA) 5,6 and, to a lesser extent, exosomes. 7,8 In patients with cancer, 1%-10% of circulating or cell-free DNA derives from tumor cells, 9 so the challenge has been to design assays that are sufficiently sensitive to detect low levels of rare mutant ctDNA among the much higher background levels of wild-type ctDNA and total cell-free DNA.…”
Section: Other Optionsmentioning
confidence: 99%
“…These include circulating tumor DNA (ctDNA) 5,6 and, to a lesser extent, exosomes. 7,8 In patients with cancer, 1%-10% of circulating or cell-free DNA derives from tumor cells, 9 so the challenge has been to design assays that are sufficiently sensitive to detect low levels of rare mutant ctDNA among the much higher background levels of wild-type ctDNA and total cell-free DNA.…”
Section: Other Optionsmentioning
confidence: 99%